Dassault to acquire ArisGlobal for compliance AI

Key Takeaways

• Dassault Systèmes to acquire ArisGlobal for approximately $1.8 billion
• ArisGlobal's AI-native compliance platform serves over 200 customers in the Life Sciences industry
• The acquisition is expected to deliver revenue synergies and be accretive to revenue growth and EPS in Year 1
• ArisGlobal's platform processes over 12 million patient safety reports annually
• The compliance market is projected to grow to $7.5 billion by 2030

Introduction to the Acquisition

Dassault Systèmes has signed a definitive agreement to acquire ArisGlobal, a leading AI-native enterprise compliance platform for the Life Sciences industry. The acquisition is valued at approximately $1.8 billion in cash at closing, with up to $200 million in additional consideration linked to multi-year AI-related revenue milestones.

About ArisGlobal

ArisGlobal's platform serves over 200 customers, including half of the Top 50 global biopharma companies, as well as biotech, medtech, CROs, and global health authorities. The company has over 1,300 employees globally and is expected to generate revenue of $175 million in 2026. ArisGlobal's regulated core platform is deeply embedded within mission-critical operations, processing over 12 million patient safety reports annually.

Market Growth and Opportunity

The compliance market is highly resilient and projected to grow double-digits to reach $7.5 billion by 2030. ArisGlobal operates in this growing market, providing innovative technology solutions to track and manage global patient safety events, medical affairs, complex regulatory submissions, and quality processes. The company's NavaX AI platform delivers over 30% productivity gains, helping customers automate complex processes, improve data quality, and strengthen compliance.

Comparison of Dassault Systèmes and ArisGlobal

Advancing Dassault Systèmes' Ambition

The acquisition of ArisGlobal advances Dassault Systèmes' ambition to transform the Life Sciences industry by combining its unique domain expertise with ArisGlobal's leadership in regulated operations and real-world evidence management. The acquisition is expected to deliver revenue synergies and be accretive to revenue growth and EPS in Year 1.

Bottom Line

The acquisition of ArisGlobal by Dassault Systèmes is a strategic move to enhance its position in the Life Sciences industry. With ArisGlobal's AI-native compliance platform and Dassault Systèmes' domain expertise, the combined entity is expected to create a unified data and intelligence platform that will generate trusted outcomes, accelerate innovation, and improve operational performance. The acquisition is expected to close in the second half of 2026, subject to regulatory approvals and other customary conditions.